Author:
Baer Lea,Muggia Franco M.,Formenti Silvia C.
Reference91 articles.
1. Sharp SY, Rogers PM, Kelland LR. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance. Clin Cancer Res 1995;1:981–9.
2. Shen DW, Goldenberg S, Pastan I, Gottesman MM. Decreased accumulation of [14C]carbo-platin in human cisplatin-resistant cells results from reduced energy-dependent uptake. J Cell Physiol 2000;183:108–16.
3. Gately, DP, SB Howell. Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer 1993;67:1171–6.
4. Kondo Y, Kuo SM, Watkins SC, Lazo JS. Metallothionein localization and cisplatin resistance in human hormone-independent prostatic tumor cell lines. Cancer Res 1995;55:474–7.
5. Perego P, Righetti SC, Supino R et al. Role of apoptosis and apoptosis-related proteins in the cisplatin-resistant phenotype of human tumor cell lines. Apoptosis 1997;2:540–8.